Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$641K Sell
3,494
-5
-0.1% -$921 ﹤0.01% 899
2025
Q4
$616K Buy
3,499
+6
+0.2% +$980 ﹤0.01% 914
2025
Q3
$489K Buy
3,493
+1
+0% +$135 ﹤0.01% 1109
2025
Q2
$439K Sell
3,492
-30,508
-90% -$3.8M ﹤0.01% 1368
2025
Q1
$4.65M Hold
34,000
0.02% 494
2024
Q4
$5.2M Sell
34,000
-15,000
-31% -$2.53M 0.02% 487
2024
Q3
$9.5M Hold
49,000
0.04% 388
2024
Q2
$11.4M Buy
+49,000
New +$10.6M 0.04% 350
2024
Q1
Sell
-5,825
Closed -$1.51M 1929
2023
Q4
$1.51M Sell
5,825
-81,114
-93% -$19.9M 0.01% 726
2023
Q3
$22.3M Sell
86,939
-46,977
-35% -$12.6M 0.1% 230
2023
Q2
$38.1M Sell
133,916
-2,837
-2% -$845K 0.16% 153
2023
Q1
$38M Buy
136,753
+203
+0.1% +$56.2K 0.16% 162
2022
Q4
$37.8M Buy
+136,550
New +$38.6M 0.17% 171
2022
Q2
Sell
-45,733
Closed -$9.63M 2054
2022
Q1
$9.63M Sell
45,733
-5,412
-11% -$1.18M 0.04% 416
2021
Q4
$12.3M Sell
51,145
-3,692
-7% -$949K 0.04% 377
2021
Q3
$15.5M Sell
54,837
-9,915
-15% -$3.25M 0.06% 331
2021
Q2
$22.4M Sell
64,752
-3,063
-5% -$928K 0.08% 284
2021
Q1
$19M Sell
67,815
-4,010
-6% -$1.08M 0.07% 291
2020
Q4
$17.6M Sell
71,825
-11,838
-14% -$3.05M 0.07% 296
2020
Q3
$23.7M Sell
83,663
-7,041
-8% -$1.96M 0.1% 230
2020
Q2
$24.3M Buy
90,704
+2,692
+3% +$809K 0.11% 218
2020
Q1
$27.8M Buy
88,012
+11,986
+16% +$3.64M 0.15% 169
2019
Q4
$22.6M Sell
76,026
-8,567
-10% -$2.38M 0.09% 256
2019
Q3
$19.7M Sell
84,593
-10,946
-11% -$2.55M 0.09% 275
2019
Q2
$22.3M Sell
95,539
-6,983
-7% -$1.61M 0.1% 254
2019
Q1
$24.2M Sell
102,522
-16,553
-14% -$5.21M 0.11% 240
2018
Q4
$35.8M Buy
119,075
+844
+0.7% +$269K 0.18% 145
2018
Q3
$41.8M Sell
118,231
-13,644
-10% -$4.7M 0.18% 149
2018
Q2
$38.3M Sell
131,875
-78,102
-37% -$22M 0.16% 173
2018
Q1
$57.5M Sell
209,977
-67,155
-24% -$20.8M 0.25% 116
2017
Q4
$88.3M Sell
277,132
-18,436
-6% -$5.91M 0.38% 58
2017
Q3
$92.5M Buy
295,568
+10,000
+4% +$2.96M 0.4% 49
2017
Q2
$77.5M Sell
285,568
-34,362
-11% -$9.09M 0.35% 69
2017
Q1
$87.5M Sell
319,930
-7,347
-2% -$2.08M 0.38% 56
2016
Q4
$92.8M Buy
327,277
+13,390
+4% +$3.97M 0.41% 50
2016
Q3
$98.3M Buy
313,887
+10,615
+4% +$3.14M 0.44% 45
2016
Q2
$73.3M Buy
303,272
+29,114
+11% +$7.67M 0.33% 75
2016
Q1
$71.4M Sell
274,158
-4,711
-2% -$1.24M 0.32% 80
2015
Q4
$85.4M Sell
278,869
-3,481
-1% -$1M 0.38% 62
2015
Q3
$82.4M Buy
282,350
+4,456
+2% +$1.47M 0.39% 57
2015
Q2
$112M Buy
277,894
+32,560
+13% +$13.1M 0.49% 40
2015
Q1
$104M Sell
245,334
-3,961
-2% -$1.56M 0.46% 45
2014
Q4
$84.6M Sell
249,295
-3,360
-1% -$1.09M 0.37% 67
2014
Q3
$83.6M Hold
252,655
0.37% 64
2014
Q2
$79.7M Buy
252,655
+31,180
+14% +$9.38M 0.36% 76
2014
Q1
$67.7M Buy
221,475
+36,500
+20% +$11.6M 0.3% 89
2013
Q4
$51.7M Buy
184,975
+7,300
+4% +$1.89M 0.23% 131
2013
Q3
$42.8M Buy
177,675
+1,035
+0.6% +$232K 0.19% 157
2013
Q2
$38M Buy
+176,640
New +$37.7M 0.16% 178

Other funds holding BIIB

STRS Ohio's BIIB Position: Q1 2026 in Review

STRS Ohio reduced its Biogen (BIIB) stake by 0.14% in Q1 2026, selling an estimated $921 and leaving 3,494 shares worth $641K. The position accounts for ﹤0.01% of the portfolio, ranked #899.

STRS Ohio first reported a position in BIIB in Q2 2013 and has held it in 49 quarters since. The position peaked at $112M in Q2 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • STRS Ohio held 3,494 shares of Biogen worth $641K as of Q1 2026.
  • STRS Ohio sold 5 Biogen shares in Q1 2026, an estimated $921.
  • Biogen made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #899 holding.
  • STRS Ohio first reported a position in Biogen in Q2 2013 and has held it in 49 quarters since.
  • STRS Ohio's Biogen position peaked at $112M in Q2 2015.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.